1. ACS Med Chem Lett. 2021 Oct 19;12(11):1643-1645. doi: 
10.1021/acsmedchemlett.1c00545. eCollection 2021 Nov 11.

Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer.

Kargbo RB(1).

Author information:
(1)Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, 
United States.

DOI: 10.1021/acsmedchemlett.1c00545
PMCID: PMC8591722
PMID: 34795853

Conflict of interest statement: The author declares no competing financial 
interest.